You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

C481S Mutation

Showing 1 - 25 of 4,570
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit

Not yet recruiting
  • Helicobacter Pylori Infection
  • +3 more
  • Detection of fecal samples with diagnostic kit
  • +2 more
  • (no location specified)
Jun 5, 2022

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)

Withdrawn
  • HIV-1 Infection
  • Dolutegravir plus lamivudine
  • Caba, Buenos Aires, Argentina
  • +1 more
Apr 5, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Advanced Solid Tumors Trial in Worldwide (Olaparib)

Recruiting
  • Advanced Solid Neoplasms
  • Tucson, Arizona
  • +128 more
Aug 18, 2022

Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Salzburg, AT, Austria
  • +29 more
Feb 23, 2022

Melanoma, Brain Metastases Trial in Canada (Dabrafenib, Trametinib)

Terminated
Has Results
  • Melanoma
  • Brain Metastases
  • Halifax, Nova Scotia, Canada
  • +5 more
Aug 18, 2021

HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

Active, not recruiting
  • HIV-1-infection
  • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
  • Antwerp, Belgium
  • +28 more
May 23, 2022

Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Loss of Chromosome 17p
  • (no location specified)
Oct 29, 2021

NSCLC Trial in Worldwide (RMC-4630, Sotorasib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Fort Myers, Florida
  • +38 more
Aug 15, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bari, Italy
  • +19 more
Mar 1, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Los Alamitos, California
  • +154 more
Jan 12, 2023

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +93 more
Nov 10, 2022

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

B-Cell Malignancies Trial in Canton, Houston (TT-01488)

Recruiting
  • B-Cell Malignancies
  • Canton, Ohio
  • +1 more
Jun 8, 2022

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,

Recruiting
  • Advanced Cancer
  • +2 more
  • Birmingham, Alabama
  • +97 more
Jan 6, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Canada, United States (Enasidenib, Enasidenib

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +17 more
Jun 21, 2021

Amyotrophic Lateral Sclerosis Trial in Worldwide (BIIB067, Placebo)

Completed
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +39 more
Jul 15, 2022

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Completed
Has Results
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +24 more
Aug 25, 2022